HC Wainwright & Co. Maintains Buy on Dare Bioscience, Raises Price Target to $6

HC Wainwright & Co. analyst Douglas Tsao maintains Dare Bioscience (NASDAQ:DARE) with a Buy and raises the price target from $5 to $6.

HC Wainwright & Co. analyst Douglas Tsao maintains Dare Bioscience (NASDAQ:DARE) with a Buy and raises the price target from $5 to $6.

Total
0
Shares
Related Posts